- Home
- Publications
- Publication Search
- Publication Details
Title
Current Understanding of Rheumatoid Arthritis Therapy
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 91, Issue 4, Pages 607-620
Publisher
Springer Nature
Online
2012-02-22
DOI
10.1038/clpt.2011.325
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-23: A key cytokine in inflammatory diseases
- (2011) Emilie Duvallet et al. ANNALS OF MEDICINE
- Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases?
- (2011) E. Neumann et al. ARTHRITIS AND RHEUMATISM
- Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK
- (2011) Charles F. Spurlock et al. ARTHRITIS AND RHEUMATISM
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- The burden of illness of rheumatoid arthritis
- (2011) Annelies Boonen et al. CLINICAL RHEUMATOLOGY
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- Does Anti-Tumor Necrosis Factor- Therapy Affect Risk of Serious Infection and Cancer in Patients with Rheumatoid Arthritis?: A Review of Longterm Data
- (2011) E. C. KEYSTONE JOURNAL OF RHEUMATOLOGY
- Induction of immune tolerance in the treatment of rheumatoid arthritis
- (2011) Salvatore Albani et al. Nature Reviews Rheumatology
- Interleukin-33 biology with potential insights into human diseases
- (2011) Gaby Palmer et al. Nature Reviews Rheumatology
- Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
- (2011) P. Engel et al. PHARMACOLOGICAL REVIEWS
- New drugs beyond biologics in rheumatoid arthritis: the kinase inhibitors
- (2011) M. G. Bonilla-Hernan et al. RHEUMATOLOGY
- The IL-17 pathway as a major therapeutic target in autoimmune diseases
- (2010) Yan Hu et al. Annals of the New York Academy of Sciences
- Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives
- (2010) G. D. Kitas et al. ANNALS OF THE RHEUMATIC DISEASES
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) D. Aletaha et al. ANNALS OF THE RHEUMATIC DISEASES
- Targeting the B Cell in Rheumatoid Arthritis
- (2010) Stanley B. Cohen BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases
- (2010) Peter C Taylor CURRENT OPINION IN PHARMACOLOGY
- Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
- (2010) A. J. Hueber et al. JOURNAL OF IMMUNOLOGY
- Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
- (2010) R. F. van VOLLENHOVEN et al. JOURNAL OF RHEUMATOLOGY
- Improving the Routine Management of Rheumatoid Arthritis: The Value of Tight Control
- (2010) P. J. MEASE JOURNAL OF RHEUMATOLOGY
- TNF receptor 2 pathway: drug target for autoimmune diseases
- (2010) Denise Faustman et al. NATURE REVIEWS DRUG DISCOVERY
- IL-1 pathways in inflammation and human diseases
- (2010) Cem Gabay et al. Nature Reviews Rheumatology
- Abatacept treatment for rheumatoid arthritis
- (2010) M. Schiff RHEUMATOLOGY
- Interleukin-1 (IL-1 ) Processing Pathway
- (2010) A. Weber et al. Science Signaling
- Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodies
- (2010) Marie-Caroline Guzian et al. ARTHRITIS CARE & RESEARCH
- Rheumatoid arthritis
- (2009) Lars Klareskog et al. LANCET
- Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study
- (2008) M H Buch et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses
- (2008) Minoru Fujimoto et al. ARTHRITIS AND RHEUMATISM
- Immune-mediated pathways in chronic inflammatory arthritis
- (2008) Claire L. Gorman et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
- (2008) N. Nishimoto et al. BLOOD
- (Re)defining biopharmaceutical
- (2008) Ronald A Rader NATURE BIOTECHNOLOGY
- IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF- and IL-17
- (2008) M. Hashizume et al. RHEUMATOLOGY
- T cells in rheumatoid arthritis
- (2008) Andrew P Cope ARTHRITIS RESEARCH & THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started